Markus is a Versant Partner located in Basel where he plays a central role in the launch of future NewCos from Versant's Ridgeline Discovery Engine.

He is a seasoned executive with deep domain knowledge of drug discovery and development, especially in the protein field. Markus most recently was CSO and a member of the management board of MorphoSys having joined in 2002. He is recognised as an authority in the field of protein engineering.

Markus holds a Ph.D. from the Technical University of Stuttgart, Germany.